Vanderbilt University Medical Center in Nashville contributed to a new COVID-19 treatment pill. It’s now under review for use in the U.S.
Great news. A new technology developed at Vanderbilt may push monoclonal antibody therapies to the next level in the fight against COVID-19.
Vanderbilt recently announced a vaccination mandate for all employees including those at Vanderbilt Tullahoma and Vanderbilt Bedford County.